Literature DB >> 30158602

The emergence of Zika virus and its new clinical syndromes.

Theodore C Pierson1, Michael S Diamond2,3,4,5.   

Abstract

Zika virus (ZIKV) is a mosquito-transmitted flavivirus that has emerged as a global health threat because of its potential to generate explosive epidemics and ability to cause congenital disease in the context of infection during pregnancy. Whereas much is known about the biology of related flaviviruses, the unique features of ZIKV pathogenesis, including infection of the fetus, persistence in immune-privileged sites and sexual transmission, have presented new challenges. The rapid development of cell culture and animal models has facilitated a new appreciation of ZIKV biology. This knowledge has created opportunities for the development of countermeasures, including multiple ZIKV vaccine candidates, which are advancing through clinical trials. Here we describe the recent advances that have led to a new understanding of the causes and consequences of the ZIKV epidemic.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30158602     DOI: 10.1038/s41586-018-0446-y

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  131 in total

1.  Persistent Zika Virus Clinical Susceptibility despite Reduced Viral Burden in Mice with Expanded Virus-Specific CD8+ T Cells Primed by Recombinant Listeria monocytogenes.

Authors:  Ashley R Burg; John J Erickson; Lucien H Turner; Giang Pham; Jeremy M Kinder; Sing Sing Way
Journal:  J Immunol       Date:  2020-06-10       Impact factor: 5.422

2.  Zika Virus Causes Acute and Chronic Prostatitis in Mice and Macaques.

Authors:  Jacques Halabi; Brett W Jagger; Vanessa Salazar; Emma S Winkler; James P White; Peter A Humphrey; Alec J Hirsch; Daniel N Streblow; Michael S Diamond; Kelle Moley
Journal:  J Infect Dis       Date:  2020-04-07       Impact factor: 5.226

Review 3.  The continued threat of emerging flaviviruses.

Authors:  Theodore C Pierson; Michael S Diamond
Journal:  Nat Microbiol       Date:  2020-05-04       Impact factor: 17.745

4.  Envelope Protein Glycosylation Mediates Zika Virus Pathogenesis.

Authors:  Derek L Carbaugh; Ralph S Baric; Helen M Lazear
Journal:  J Virol       Date:  2019-05-29       Impact factor: 5.103

5.  Atovaquone Inhibits Arbovirus Replication through the Depletion of Intracellular Nucleotides.

Authors:  Angelica Cifuentes Kottkamp; Elfie De Jesus; Rebecca Grande; Julia A Brown; Adam R Jacobs; Jean K Lim; Kenneth A Stapleford
Journal:  J Virol       Date:  2019-05-15       Impact factor: 5.103

Review 6.  Type III IFNs: Beyond antiviral protection.

Authors:  Sergei V Kotenko; Amariliz Rivera; Dane Parker; Joan E Durbin
Journal:  Semin Immunol       Date:  2019-06       Impact factor: 11.130

7.  Atlastin Endoplasmic Reticulum-Shaping Proteins Facilitate Zika Virus Replication.

Authors:  Blandine Monel; Maaran Michael Rajah; Mohamed Lamine Hafirassou; Samy Sid Ahmed; Julien Burlaud-Gaillard; Peng-Peng Zhu; Quentin Nevers; Julian Buchrieser; Françoise Porrot; Cécile Meunier; Sonia Amraoui; Maxime Chazal; Audrey Salles; Nolwenn Jouvenet; Philippe Roingeard; Craig Blackstone; Ali Amara; Olivier Schwartz
Journal:  J Virol       Date:  2019-11-13       Impact factor: 5.103

8.  Explaining Pathogenicity of Congenital Zika and Guillain-Barré Syndromes: Does Dysregulation of RNA Editing Play a Role?

Authors:  Helen Piontkivska; Noel-Marie Plonski; Michael M Miyamoto; Marta L Wayne
Journal:  Bioessays       Date:  2019-05-20       Impact factor: 4.345

9.  Genetic Diversity of Collaborative Cross Mice Controls Viral Replication, Clinical Severity, and Brain Pathology Induced by Zika Virus Infection, Independently of Oas1b.

Authors:  Caroline Manet; Etienne Simon-Lorière; Grégory Jouvion; David Hardy; Matthieu Prot; Laurine Conquet; Marie Flamand; Jean-Jacques Panthier; Anavaj Sakuntabhai; Xavier Montagutelli
Journal:  J Virol       Date:  2020-01-17       Impact factor: 5.103

Review 10.  Protective and Pathogenic Effects of Interferon Signaling During Pregnancy.

Authors:  Rebecca L Casazza; Helen M Lazear; Jonathan J Miner
Journal:  Viral Immunol       Date:  2019-09-23       Impact factor: 2.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.